Saturn V Capital Management LP: VAXCYTE INC (PCVX): Quarterly 13F Position History
As of Q2 2026, Saturn V Capital Management LP reported 852,914 shares of VAXCYTE INC (PCVX), worth $49.6M and representing 7.1% of its 13F equity book. Quarter-over-quarter share count change: + 28,382 (+3.4%) . The position first appeared in Q1 2024 and has been disclosed across 10 13F-HR filings in Pactolio's tracked window.
- 852,914Shares Held (Latest Filing)
- $49.6MReported Market Value (Latest Filing)
- 7.1%Portfolio Weight (% of 13F Equity Book)
- +28,382Quarter-over-Quarter Share Change
- +$1.7MQuarter-over-Quarter Value Change
- 852,914Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 10 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 852,914 | +28,382 | +3.4% | $49.6M | 7.1% | $58.1 |
| Q1 2026 | 824,532 | +25,592 | +3.2% | $47.9M | 8.7% | $58.1 |
| Q4 2025 | 798,940 | +10,499 | +1.3% | $36.9M | 6.8% | $46.1 |
| Q3 2025 | 788,441 | +244,220 | +44.9% | $28.4M | 6.2% | $36.0 |
| Q2 2025 | 544,221 | +311,926 | +134.3% | $17.7M | 7.2% | $32.5 |
| Q1 2025 | 232,295 | +28,010 | +13.7% | $8.8M | 4.4% | $37.8 |
| Q4 2024 | 204,285 | 702 | -0.3% | $16.7M | 6.5% | $81.9 |
| Q3 2024 | 204,987 | 10,693 | -5.0% | $23.4M | 8.4% | $114.3 |
| Q2 2024 | 215,680 | +30,505 | +16.5% | $16.3M | 6.2% | $75.5 |
| Q1 2024 | 185,175 | – | – | $12.6M | 5.1% | $68.3 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Saturn V Capital Management LP first disclose a PCVX position in 13F-HR filings?
Saturn V Capital Management LP first reported VAXCYTE INC (PCVX) on its 13F-HR filing for the period ending 2024-03-31 (Q1 2024). The position has appeared on 10 reported quarters within Pactolio's tracked window.
What was Saturn V Capital Management LP's most recent quarter-over-quarter share-count change in PCVX?
Between Q1 2026 and Q2 2026, Saturn V Capital Management LP added 28,382 shares of PCVX (+3.4%), bringing the total reported position to 852,914 shares at a market value of $49.6M.
Does the implied price-per-share represent Saturn V Capital Management LP's cost basis in PCVX?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.